The acquisition of privately held Velocity11 enables Agilent to offer a more comprehensive suite to its life science customers in the pharmaceutical, biotech and academic research markets
Agilent Technologies has completed the acquisition of Velocity11, a provider of automated liquid handling and laboratory robotics for the life science market.
Velocity11's technology strengthens Agilent's offering of automated sample-preparation solutions across a broad range of applications.
"With the acquisition now complete, we look to developing strong synergies between Velocity11 and Agilent," said Nick Roelofs, vice president of Agilent's life sciences unit.
"Agilent can now offer customers an enhanced set of comprehensive workflow solutions in the pharmaceutical, government and academic segments, leveraging a strong portfolio in automation, detection, measurement and informatics".
"With Agilent's strong customer relationships, commitment to quality and global reach, we should be able to take Velocity11's products to the next level of market penetration," said Rob Nail, former Velocity11 CEO and now general manager of the company within Agilent.
Velocity11 designs, manufactures and markets robotics that range from standalone instrumentation to bench-top automation to large, multi-armed robotic systems.
The company also develops world-class software to control the robotics.
Velocity11's customers comprise most of the major pharmaceutical and biotechnology companies as well as leading genome centers and academic institutions.
Substantially all of Velocity11's approximately 150 employees worldwide have now joined Agilent.
Headquartered in Menlo Park, Calif, Velocity11 has a second office in Melbourn, Hertfordshire, UK, with field sales and support offered throughout the USA and western Europe.
